Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (71-80 of 284) with videos related to

Pageof 29
Sort By:
Mathematical Biosciences|November 26, 2002
Cancer treatment by telomerase inhibitors: predictions by a kinetic modelIgor A Sidorov, Ken S Hirsch, Calvin B Harley, et al.
ACS Applied Materials & Interfaces|September 7, 2017
Graphene Oxide-Polycarbonate Track-Etched Nanosieve Platform for Sensitive Detection of Human Immunodeficiency Virus Envelope GlycoproteinAnuj Nehra, Weizao Chen, Dimiter S Dimitrov, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastomaNan Li, Haiying Fu, Stephen M Hewitt, et al.
Journal of Theoretical Biology|November 5, 2002
Cancer cell dynamics in presence of telomerase inhibitors: analysis of in vitro dataIgor A Sidorov, Ken S Hirsch, Calvin B Harley, et al.
Frontiers in Immunology|April 25, 2022
Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22Zehua Sun, Wei Li, John W Mellors, et al.
Biochemical and Biophysical Research Communications|July 21, 2009
A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitorsXiaodong Xiao, Yang Feng, Bang K Vu, et al.
Frontiers in Immunology|April 26, 2014
Interactions of IgG1 CH2 and CH3 Domains with FcRnTianlei Ying, Tina W Ju, Yanping Wang, et al.
Biochimica Et Biophysica Acta|May 6, 2014
Engineered Fc based antibody domains and fragments as novel scaffoldsTianlei Ying, Rui Gong, Tina W Ju, et al.
The Journal of Biological Chemistry|July 23, 2013
Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeuticsTianlei Ying, Weizao Chen, Yang Feng, et al.
Biochemical and Biophysical Research Communications|February 17, 2017
Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregationDezhi Li, Rui Gong, Jun Zheng, et al.
Pageof 29

Showing results (71-80 of 284) with videos related to

Sort By:
Pageof 29
Mathematical Biosciences|November 26, 2002
Cancer treatment by telomerase inhibitors: predictions by a kinetic modelIgor A Sidorov, Ken S Hirsch, Calvin B Harley, et al.
ACS Applied Materials & Interfaces|September 7, 2017
Graphene Oxide-Polycarbonate Track-Etched Nanosieve Platform for Sensitive Detection of Human Immunodeficiency Virus Envelope GlycoproteinAnuj Nehra, Weizao Chen, Dimiter S Dimitrov, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastomaNan Li, Haiying Fu, Stephen M Hewitt, et al.
Journal of Theoretical Biology|November 5, 2002
Cancer cell dynamics in presence of telomerase inhibitors: analysis of in vitro dataIgor A Sidorov, Ken S Hirsch, Calvin B Harley, et al.
Frontiers in Immunology|April 25, 2022
Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22Zehua Sun, Wei Li, John W Mellors, et al.
Biochemical and Biophysical Research Communications|July 21, 2009
A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitorsXiaodong Xiao, Yang Feng, Bang K Vu, et al.
Frontiers in Immunology|April 26, 2014
Interactions of IgG1 CH2 and CH3 Domains with FcRnTianlei Ying, Tina W Ju, Yanping Wang, et al.
Biochimica Et Biophysica Acta|May 6, 2014
Engineered Fc based antibody domains and fragments as novel scaffoldsTianlei Ying, Rui Gong, Tina W Ju, et al.
The Journal of Biological Chemistry|July 23, 2013
Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeuticsTianlei Ying, Weizao Chen, Yang Feng, et al.
Biochemical and Biophysical Research Communications|February 17, 2017
Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregationDezhi Li, Rui Gong, Jun Zheng, et al.
Pageof 29